SCA
ABBV icon

Stokes Capital Advisors’s AbbVie ABBV Stock Holding History

Stokes Capital Advisors’s Portfolio ABBV Stock Details ABBV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$9.43M Buy
37,456
+618
+2% +$133K 2.02% 17
2026
Q1 		$8.01M Buy
36,838
+315
+0.9% +$69.9K 1.8% 26
2025
Q4 		$8.35M Sell
36,523
-1,256
-3% -$286K 1.91% 22
2025
Q3 		$8.75M Sell
37,779
-340
-0.9% -$69.2K 2.04% 18
2025
Q2 		$7.08M Buy
38,119
+1,349
+4% +$251K 1.73% 24
2025
Q1 		$7.7M Buy
36,770
+69
+0.2% +$13.4K 1.96% 23
2024
Q4 		$6.52M Buy
36,701
+1,594
+5% +$293K 1.68% 25
2024
Q3 		$6.93M Buy
35,107
+6
+0% +$1.12K 1.78% 29
2024
Q2 		$6.02M Buy
35,101
+7,652
+28% +$1.27M 1.67% 31
2024
Q1 		$5M Buy
27,449
+324
+1% +$55.8K 1.45% 37
2023
Q4 		$4.2M Buy
27,125
+25,735
+1,851% +$3.75M 1.33% 37
2023
Q3 		$207K Buy
+1,390
New +$204K 0.07% 79
2023
Q2 		– Sell
-1,390
Closed -$222K – 81
2023
Q1 		$222K Hold
1,390
– – 0.08% 81
2022
Q4 		$225K Buy
+1,390
New +$213K 0.08% 84

Other funds holding ABBV

LMFP
Larry Mathis Financial Planning Phoenix, Arizona $124B AUM
Robeco Institutional Asset Management
Robeco Institutional Asset Management Rotterdam, Netherlands $81.4B AUM 40.71% 1-Year Est. Return
Swedbank
Swedbank Stockholm, Sweden $116B AUM 46.87% 1-Year Est. Return
Assenagon Asset Management
Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.57% 1-Year Est. Return
ATO
Alecta Tjanstepension Omsesidigt Stockholm, Sweden $23.8B AUM 34.25% 1-Year Est. Return
New York State Teachers Retirement System (NYSTRS)
New York State Teachers Retirement System (NYSTRS) Albany, New York $54.2B AUM 43.77% 1-Year Est. Return
Handelsbanken Fonder
Handelsbanken Fonder Stockholm, Sweden $35.1B AUM 47.76% 1-Year Est. Return
HCM
Hamlin Capital Management New York $4.45B AUM 22.95% 1-Year Est. Return
AAMU
AEGON Asset Management (UK) Edinburgh, United Kingdom $9.38B AUM 48.94% 1-Year Est. Return
FWCM
Ferguson Wellman Capital Management Portland, Oregon $8.19B AUM 30.56% 1-Year Est. Return

Stokes Capital Advisors's ABBV Position: Q2 2026 in Review

Stokes Capital Advisors increased its AbbVie (ABBV) stake by 1.7% in Q2 2026, buying an estimated $133K and bringing the position to 37,456 shares worth $9.43M. The position accounts for 2.02% of the portfolio, ranked #17.

Stokes Capital Advisors first reported a position in ABBV in Q4 2022 and has held it in 14 quarters since. 1,476 funds tracked by Wall St. Rank hold ABBV as of Q2 2026.

  • Stokes Capital Advisors held 37,456 shares of AbbVie worth $9.43M as of Q2 2026.
  • Stokes Capital Advisors bought 618 AbbVie shares in Q2 2026, an estimated $133K.
  • AbbVie made up 2.02% of Stokes Capital Advisors's portfolio in Q2 2026, its #17 holding.
  • Stokes Capital Advisors first reported a position in AbbVie in Q4 2022 and has held it in 14 quarters since.
  • 1,476 funds tracked by Wall St. Rank held AbbVie as of Q2 2026.

Based on Stokes Capital Advisors's 13F filing for Q2 2026, filed 22 Jul 2026.